Structure

Physi-Chem Properties

Molecular Weight:  742.33
Volume:  722.503
LogP:  4.517
LogD:  3.915
LogS:  -2.252
# Rotatable Bonds:  6
TPSA:  203.43
# H-Bond Aceptor:  14
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.173
Synthetic Accessibility Score:  7.873
Fsp3:  0.629
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.665
MDCK Permeability:  1.8844355508917943e-05
Pgp-inhibitor:  0.963
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.021
20% Bioavailability (F20%):  0.826
30% Bioavailability (F30%):  0.977

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.838
Plasma Protein Binding (PPB):  60.64137649536133%
Volume Distribution (VD):  2.946
Pgp-substrate:  22.296138763427734%

ADMET: Metabolism

CYP1A2-inhibitor:  0.047
CYP1A2-substrate:  0.051
CYP2C19-inhibitor:  0.049
CYP2C19-substrate:  0.07
CYP2C9-inhibitor:  0.076
CYP2C9-substrate:  0.017
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.02
CYP3A4-inhibitor:  0.044
CYP3A4-substrate:  0.915

ADMET: Excretion

Clearance (CL):  1.473
Half-life (T1/2):  0.06

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  1.0
Drug-inuced Liver Injury (DILI):  0.993
AMES Toxicity:  0.003
Rat Oral Acute Toxicity:  0.093
Maximum Recommended Daily Dose:  0.926
Skin Sensitization:  0.013
Carcinogencity:  0.019
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.439

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC74917

Natural Product ID:  NPC74917
Common Name*:   Patellamide A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  ZGJIVWQOEHQWLW-SWTUTNCKSA-N
Standard InCHI:  InChI=1S/C35H50N8O6S2/c1-10-17(7)25-32-36-20(12-48-32)28(44)39-23(15(3)4)34-37-22(14-50-34)30(46)42-26(18(8)11-2)33-43-27(19(9)49-33)31(47)40-24(16(5)6)35-38-21(13-51-35)29(45)41-25/h13-20,23-27H,10-12H2,1-9H3,(H,39,44)(H,40,47)(H,41,45)(H,42,46)/t17-,18-,19+,20-,23+,24+,25-,26-,27-/m0/s1
SMILES:  CC[C@@H]([C@@H]1N=C(O)c2csc(n2)[C@H](N=C(O)[C@H]2N=C(O[C@@H]2C)[C@@H](N=C(c2nc([C@H](N=C([C@H]3N=C1OC3)O)C(C)C)sc2)O)[C@H](CC)C)C(C)C)C
Synthetic Gene Cluster:   BGC0000475;
ChEMBL Identifier:   CHEMBL448385
PubChem CID:   157454
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides
            • [CHEMONTID:0001995] Cyclic peptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[1593285]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[2095371]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[2809606]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[7623037]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. PMID[9868162]
NPO4712 Lissoclinum patella Species Didemnidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT137 Cell Line L1210 Mus musculus IC50 = 2.0 ug.mL-1 PMID[523494]
NPT91 Cell Line KB Homo sapiens IC50 = 3.0 ug.mL-1 PMID[523496]
NPT137 Cell Line L1210 Mus musculus Activity = 150.0 Zone units PMID[523496]
NPT730 Cell Line MC-38 Mus musculus Activity = 160.0 Zone units PMID[523496]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 90.0 nM PMID[523495]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 0.0 Zone units PMID[523496]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC74917 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9603 High Similarity NPC120917
0.9516 High Similarity NPC89592
0.935 High Similarity NPC267605
0.935 High Similarity NPC51692
0.9106 High Similarity NPC135558
0.879 High Similarity NPC214375
0.7688 Intermediate Similarity NPC229160
0.7688 Intermediate Similarity NPC25316
0.7688 Intermediate Similarity NPC263485
0.7625 Intermediate Similarity NPC475330
0.7603 Intermediate Similarity NPC475390
0.7582 Intermediate Similarity NPC237219
0.7578 Intermediate Similarity NPC174652
0.7552 Intermediate Similarity NPC103268
0.7453 Intermediate Similarity NPC161242
0.7346 Intermediate Similarity NPC476080
0.7346 Intermediate Similarity NPC475534
0.7255 Intermediate Similarity NPC50274
0.7143 Intermediate Similarity NPC164006
0.7081 Intermediate Similarity NPC24990
0.7 Intermediate Similarity NPC469801
0.6981 Remote Similarity NPC56058
0.6981 Remote Similarity NPC522
0.6933 Remote Similarity NPC476103
0.6928 Remote Similarity NPC132662
0.6871 Remote Similarity NPC34319
0.679 Remote Similarity NPC222391
0.677 Remote Similarity NPC110129
0.677 Remote Similarity NPC201014
0.6768 Remote Similarity NPC256912
0.6646 Remote Similarity NPC475554
0.6645 Remote Similarity NPC319751
0.6584 Remote Similarity NPC217981
0.6561 Remote Similarity NPC473398
0.6548 Remote Similarity NPC134480
0.6519 Remote Similarity NPC119481
0.6509 Remote Similarity NPC473704
0.6402 Remote Similarity NPC216720
0.6364 Remote Similarity NPC210424
0.6077 Remote Similarity NPC329961
0.6034 Remote Similarity NPC96016
0.6011 Remote Similarity NPC165538
0.5989 Remote Similarity NPC122427
0.5988 Remote Similarity NPC101980
0.5988 Remote Similarity NPC97078
0.5988 Remote Similarity NPC470146
0.5858 Remote Similarity NPC315252
0.5714 Remote Similarity NPC14101
0.5683 Remote Similarity NPC49051
0.5621 Remote Similarity NPC475568

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC74917 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6978 Remote Similarity NPD9579 Approved
0.5843 Remote Similarity NPD2957 Phase 2
0.574 Remote Similarity NPD6915 Approved
0.5695 Remote Similarity NPD6121 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data